news

Novel based editors developed

Posted: 4 September 2023 | | No comments yet

Researchers have developed a novel based CRISPR-free base editing system named CyDENT, which enables precise base editing.

In a study published in Nature Biotechnology, GAO Caixia’s team at the Institute of Genetics and Developmental Biology (IGDB) of the Chinese Academy of Sciences, in collaboration with researchers at Qi Biodesign, has introduced a novel, CRISPR-free base editing system named CyDENT. This breakthrough method enables precise base editing within the nuclei, mitochondria, and chloroplast genomes of both plant and human cells.

Genome editing has revolutionised the field of life sciences by providing an efficient means to precisely modify genetic information in living organisms. In recent years, base editing technology has further enhanced the precision and predictability of genome editing.

The development of base editing was pioneered by David Liu’s lab at the Broad Institute and Harvard University. They achieved this by merging a nickase Cas9 with single-strand DNA-specific deaminases, leading to the creation of cytosine base editor (CBE) and adenine base editor (ABE) systems. These systems allow for efficient conversions of C·G-to-T·A or A·T-to-G·C bases in the nuclear genome. Subsequently, they harnessed a newly identified dsDNA-specific deaminase, DddAtox, to develop DdCBE, which facilitates efficient C·G-to-T·A editing in organellar genomes. Jin-Soo Kim’s lab further built upon this to create TALED, enabling A·T-to-G·C base editing in mitochondrial genomes.

 

Reserve your FREE place

 


Are you looking to optimise antibody leads in your drug discovery? Register for this webinar to find out how!

30 July 2025 | 10:00 AM BST | FREE Webinar

Join this webinar to hear from Dr. Lei Guo as she shares how early insights into liability, PK, stability, and manufacturability can help you optimise antibody leads in early drug discovery – and mitigate downstream risks later in development.

What You’ll Learn:

  • How to assess key developability risks early
  • How in silico modelling and in vitro testing can be combined to predict CMC risks earlier in discovery stage
  • How micro-developability strategies are tailored for complex or novel formats

Don’t miss your chance to learn from real-world leaders

Register Now – It’s Free!

 

However, the use of DddAtox in DdCBE and TALED systems introduced unintended off-target edits due to its dsDNA deamination properties. Recently, WEI Wensheng’s team at Peking University developed mitoBEs, which are DddAtox-independent base editors, improving the precision of mitochondrial base editing.

According to GAO’s study, CyDENT comprises a pair of TALEs fused to a FokI nickase, a single-strand specific cytidine deaminase, an exonuclease, and an uracil glycosylase inhibitor peptide. The process begins with the nickase creating nicks in the target DNA strand guided by TALEs. Subsequently, the exonuclease recognizes and digests the nicked DNA strand, exposing a short single-strand DNA fragment that serves as a substrate for single-strand DNA-specific deamination.

This unique strategy allows for editing of single-strand DNA without the need for a Cas9-guided R-loop structure, effectively eliminating the involvement of dsDNA deaminases. Importantly, the entire CyDENT complex is devoid of RNA, enabling strand-specific base editing in both nuclear and organellar genomes.

The researchers conducted evaluations of CyDENT base editing in rice protoplasts, targeting nuclear and chloroplast sites, as well as in HEK293T cells, targeting mitochondrial sites. They demonstrated effective base editing, achieving editing efficiencies of nearly 40 percent in the mitochondrial genome with a high degree of strand specificity. Additionally, they successfully edited TC or GC motifs using newly developed ssDNA deaminases from the same research groups, highlighting the flexibility and modularity of the CyDENT system.

The advancement of CyDENT base editors expands the toolbox of precision genome editing technologies for both nuclear and organelle genome editing, facilitating improved genetic designs. This development holds great promise across various research domains, including the treatment of genetic diseases, the development of sustainable agricultural varieties, and the engineering of diverse microbiomes.

Leave a Reply

Your email address will not be published. Required fields are marked *